ADITYA BIRLA SUNLIFE LIFE PHARMA AND HEALTHCARE FUND NORMAL GROWTH

Thematic • Very High Risk

ADITYA BIRLA SUNLIFE LIFE PHARMA AND HEALTHCARE FUND NORMAL GROWTH

Category: Thematic

CRISIL Rating: Very High Risk

Code: BS60B-GR

NAV

₹30.65

0.37 (1.20%)
2026-02-19
Fund Rating

3 ⭐

Fund Information
Fund Size (AUM): 81.20 CR
Fund Strategy: Very High Risk
Expense Ratio: 2.3000%
Fund Manager:
Min Lump Sum: ₹1,000.00
Min SIP: ₹100.00
ISIN: INF209KB1N91
Benchmark:
22.43% 3Y annualised
NAV

₹30.65

2026-02-19
Fund Rating

3 ⭐

Fund Size

81.20 CR

Fund Strategy

Very High Risk

₹500 ₹100,000
Total Investment: ₹15,000
Total Value: ₹0
Login to Invest

Login to create portfolios and start investing

Sector Allocation
Top Holdings
Security Name Weight (%)
Sun Pharmaceuticals Industries Ltd 11.69%
Cipla Ltd 7.65%
Apollo Hospitals Enterprise Ltd 7.32%
Abbott India Ltd 6.92%
Torrent Pharmaceuticals Ltd 5.41%
Fortis Healthcare Ltd 4.99%
Lupin Ltd 4.52%
Ajanta Pharma Ltd 3.96%
Aurobindo Pharma Ltd 3.66%
Ipca Laboratories Ltd 3.64%

Fund Rating

3 out of 5

Funds in Same Category

No other funds found in this category.